Fangsheng Pharma: Controlling shareholder increases stake, plans further buys

Hunan Fangsheng Pharmaceutical (SSE: 603998) announced that Zhang Zurong, a party acting in concert with controlling shareholder Zhang Qinghua, has purchased 10,000 shares of the company on February 11, 2025, at a total value of ¥94,800. This represents approximately 0.0023% of the company's total share capital. Furthermore, Zhang Zurong intends to continue increasing her holdings through open market purchases between February 11, 2025, and August 10, 2025, with a planned investment of no less than ¥2 million and no more than ¥4 million (including the initial purchase). The company noted potential risks including market fluctuations or policy changes affecting the implementation of the plan. The insider currently holds a collective 37.61% of the company shares.